![Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk]()
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular riskArsenault, Benoit J.; Petrides, Francine; Tabet, Fatiha; Bao, Weihang; Hovingh, G. Kees; Boekholdt, S. Matthijs; Ramin-Mangata, Stéphane; Meilhac, Olivier; DeMicco, David; Rye, Kerry-Anne; Waters, David D.; Kastelein, John J.P.; Barter, Philip; Lambert, Gilles · Journal of Clinical Lipidology · 2017